Skip to main content
. 2020 Aug 26;11:2053. doi: 10.3389/fmicb.2020.02053

FIGURE 5.

FIGURE 5

In vivo topical application of TCH-1140 against ATCC10231: (A) the skin surface of ATCC10231-infected mice after treatment of 5-FC or TCH-1140 viewed under phenotypic and microscopic images; (B) ATCC10231 CFU in mouse skin after treatment of 5-FC or TCH-1140; (C) TEWL of ATCC10231-infected mice after treatment of 5-FC or TCH-1140; and (D) histological observation of ATCC10231-infected mouse skin biopsy stained by H&E. All data are presented as the mean of six experiments ±SD. ***p < 0.001, **p < 0.01, *p < 0.05.